|
🐢
|
Performance of near-infrared spectroscopy in measuring local O(2) consumption and blood flow in skeletal muscle.
M. Beekvelt,
W. Colier,
R. Wevers,
B. Engelen
|
9 |
2001 |
9
🐢
|
|
🐜
|
Autoantibody profiles in the sera of European patients with myositis
18 auth.
R. Brouwer,
G. Hengstman,
W. V. Egberts,
H. Ehrfeld,
B. Božič,
A. Ghirardello,
G. Gröndal,
M. Hietarinta,
D. Isenberg,
J. Kalden,
...
I. Lundberg,
H. Moutsopoulos,
P. Roux‐Lombard,
J. Vencovský,
A. Wikman,
H. Seelig,
B. Engelen,
W. V. Venrooij
|
8 |
2001 |
8
🐜
|
|
🐢
|
Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy
10 auth.
G. Hengstman,
H. Laak,
W. V. Egberts,
I. Lundberg,
H. Moutsopoulos,
J. Vencovský,
...
A. Doria,
M. Mosca,
W. V. Venrooij,
B. Engelen
|
8 |
2006 |
8
🐢
|
|
🐜
|
The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength.
10 auth.
M. Worm-Smeitink,
M. Gielissen,
Lotte Bloot,
H. Laarhoven,
B. Engelen,
P. Riel,
...
G. Bleijenberg,
S. Nikolaus,
H. Knoop,
H. Knoop
|
7 |
2017 |
7
🐜
|
|
🐜
|
Autoantibodies to cytosolic 5′‐nucleotidase 1A in inclusion body myositis
14 auth.
H. Pluk,
B. J. Hoeve,
Sander H. J. Dooren,
Judith Stammen-Vogelzangs,
A. Heijden,
H. J. Schelhaas,
M. Verbeek,
U. Badrising,
S. Arnardóttir,
K. Gheorghe,
...
I. Lundberg,
W. Boelens,
B. Engelen,
G. Pruijn
|
7 |
2013 |
7
🐜
|
|
🐜
|
Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis.
8 auth.
A. Verrips,
L. Hoefsloot,
G. Steenbergen,
J. Theelen,
R. Wevers,
F. Gabreëls,
...
B. Engelen,
L. Heuvel
|
7 |
2000 |
7
🐜
|
|
🐜
|
Epidemiology of inclusion body myositis in the Netherlands: A nationwide study
16 auth.
U. Badrising,
M. Maat-Schieman,
S. V. Duinen,
F. Breedveld,
P. Doorn,
B. Engelen,
F. V. D. Hoogen,
J. Hoogendijk,
C. Höweler,
A. D. Jager,
...
F. Jennekens,
P. Koehler,
H. Leeuw,
M. Visser,
J. Verschuuren,
A. Wintzen
|
7 |
2000 |
7
🐜
|
|
🐜
|
Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis
29 auth.
N. Dlamini,
N. Voermans,
S. Lillis,
K. Stewart,
E. Kamsteeg,
G. Drost,
R. Quinlivan,
M. Snoeck,
F. Norwood,
A. Radunović,
V. Straub,
M. Roberts,
A. Vrancken,
W. Pol,
R. D. Coo,
...
A. Manzur,
S. Yau,
S. Abbs,
A. King,
M. Lammens,
P. Hopkins,
S. Mohammed,
S. Treves,
F. Muntoni,
E. Wraige,
M. Davis,
B. Engelen,
H. Jungbluth,
H. Jungbluth
|
7 |
2013 |
7
🐜
|
|
🐜
|
Polymyositis: An overdiagnosed entity
24 auth.
F. Miller,
L. Rider,
P. Plotz,
S. Rutkove,
A. Pestronk,
R. Wortmann,
I. Lundberg,
Z. Argov,
D. Isenberg,
D. Lacomis,
...
C. Oddis,
W. Bradley,
G. Hengstman,
B. Engelen,
M. V. D. Meulen,
I. Bronner,
J. Hoogendijk,
H. Burger,
W. V. Venrooij,
A. Voskuyl,
H. Dinant,
W. Linssen,
J. Wokke,
M. Visser
|
7 |
2004 |
7
🐜
|
|
🐜
|
Clinical features of facioscapulohumeral muscular dystrophy 2
17 auth.
J. D. Greef,
R. Lemmers,
P. Camaño,
J. Day,
S. Sacconi,
M. Dunand,
B. Engelen,
S. Kiuru-Enari,
G. Padberg,
A. L. Rosa,
...
C. Desnuelle,
Simone Spuler,
M. Tarnopolsky,
S. Venance,
R. Frants,
S. M. Maarel,
R. Tawil
|
7 |
2010 |
7
🐜
|
|
🐜
|
Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis.
11 auth.
A. Verrips,
R. Wevers,
B. Engelen,
A. Keyser,
B. G. Wolthers,
F. Barkhof,
...
A. Stalenhoef,
R. Graaf,
F. S. M. Janssen-Zijlstra,
A. Spreeken,
F. Gabreëls
|
6 |
1999 |
6
🐜
|
